Article
Matrix metalloproteinase-2 promoter polymorphism is associated with breast cancer in a Mexican population.
Gynecologic and obstetric investigation - 1 Jan 2008
Delgado-Enciso Iván, Cepeda-Lopez Friedman R, Monrroy-Guizar Elisa A, Bautista-Lam Jose R, Andrade-Soto Maricela, Jonguitud-Olguin Gregorio, Rodriguez-Hernandez Alejandrina, Anaya-Ventura Aristoteles, Baltazar-Rodriguez Luz M, Orozco-Ruiz Martha, Soriano-Hernandez Alejandro D, Rodriguez-Sanchez Iram P, Lugo-Trampe Angel, Espinoza-Gomez Francisco, Michel-Peregrina Martha L
Abstract excerpt
BACKGROUND: Matrix metalloproteinase-2 (MMP-2) is an enzyme with proteolytic activity on matrix proteins, particularly basement membrane constituents. A single nucleotide polymorphism C>T transition at -1306 displayed a strong association with several cancers. Our study investigated whether or not the MMP-2 -1306C>T polymorphism contributed to the development of breast cancer (BC) in a Mexican population....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
